ASLAN Pharmaceuticals

ASLN

NASDAQHealth Care

Income Statement

Total Revenue$0

Gross Profit$0

Operating Income$-37.16M

EBITDA$-157.63M

EBIT$-37.01M

Pre-tax Income$-37.48M

Net Income$-39.68M

Net Cash$408.18M

Cash Equivalent$18.4M

Total Debt$26.67M

Net Debt$-381.51M

Book Value$-17.96M

Net Cash Per Share1.21

Book Value Per Share-0.04

Return on Equity (ROE)-614.24%

Return on Assets (ROA)-83.98%

Return on Invested Capital (ROI)-111.74%

Net Profit Margin-1567.33%

Current Ratio2.63

Quick Ratio2.50

Long-Term Debt / Equity3.55